Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02300909 · ClinicalTrials.gov registry record · NA

dHACM in Lumbar Decompression and Microdiscectomy Surgery

A NA study of Spinal Stenosis and Scarring, sponsored by MiMedx Group.

Completed
Registry status
NA
Development phase
143
Enrollment target
1
Study location

NCT02300909 is a NA study of Spinal Stenosis and Scarring that has completed, run by MiMedx Group. The registered enrollment target is 143 participants, below the 540-participant average among 15 other Spinal Stenosis trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02300909, a NA study of Spinal Stenosis and Scarring, has completed, sponsored by MiMedx Group.

COMPLETED
Registry status
NA
Development phase
143 participants
Enrollment target
1
Study location

Study Summary

Prospective evaluation of the safety and efficacy of dHACM on clinical outcomes in lumbar laminectomy and microdiscectomy patients as assessed by Oswestry Disability Index.

Interventions

  • PROCEDURE Lumbar Decompression Surgery
  • PROCEDURE Microdiscectomy Surgery
  • OTHER Dehydrated Human Amnion/Chorion Membrane (dHACM)

Study Locations (1)

New York

  • Hospital for Special Surgery - New York

Trial Details

FieldValue
Enrollment Target 143 participants
Start Date 2014-11
Est. Completion 2018-06
Phase NA

Sponsor

MiMedx Group

32 total trials

What the Registry Record Tells You About NCT02300909

The ClinicalTrials.gov registry entry for NCT02300909 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 143 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 540-participant average among 15 other Spinal Stenosis trials with a reported enrollment target (74% lower). The listed sponsor is MiMedx Group, which has 32 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Spinal Stenosis appearing as the primary indexed condition, and to 3 interventions - of which Lumbar Decompression Surgery is the first listed.

NCT02300909 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT02300909 about?

NCT02300909 is a clinical study titled "dHACM in Lumbar Decompression and Microdiscectomy Surgery". Prospective evaluation of the safety and efficacy of dHACM on clinical outcomes in lumbar laminectomy and microdiscectomy patients as assessed by Oswestry Disability Index.

What is the current status of trial NCT02300909?

This trial is currently completed. It is a NA study. The enrollment target is 143 participants. The study started on 2014-11. Estimated completion is 2018-06.

What conditions does trial NCT02300909 study?

This clinical trial studies the following conditions: Spinal Stenosis, Scarring, Herniated Disc.

What interventions are being tested in trial NCT02300909?

The interventions under investigation include: Lumbar Decompression Surgery (PROCEDURE), Microdiscectomy Surgery (PROCEDURE), Dehydrated Human Amnion/Chorion Membrane (dHACM) (OTHER).

Who is sponsoring clinical trial NCT02300909?

This trial is sponsored by MiMedx Group, which has 32 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02300909 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Stenosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.